Bausch + Lomb Corporation

NYSE:BLCO

11.5 (USD) • At close May 8, 2025
Bedrijfsnaam Bausch + Lomb Corporation
Symbool BLCO
Munteenheid USD
Prijs 11.5
Beurswaarde 4,064,061,360
Dividendpercentage 0%
52-weken bereik 10.45 - 21.69
Industrie Medical Instruments & Supplies
Sector Healthcare
CEO Mr. Brenton L. Saunders J.D.
Website https://www.bausch.com

An error occurred while fetching data.

Over Bausch + Lomb Corporation

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact

Vergelijkbare Aandelen

Penumbra, Inc. logo

Penumbra, Inc.

PEN

288.73 USD

Perrigo Company plc logo

Perrigo Company plc

PRGO

26.8 USD

Teladoc Health, Inc. logo

Teladoc Health, Inc.

TDOC

7.08 USD

Encompass Health Corporation logo

Encompass Health Corporation

EHC

115.91 USD

Ginkgo Bioworks Holdings, Inc. logo

Ginkgo Bioworks Holdings, Inc.

DNA

7.87 USD

Inspire Medical Systems, Inc. logo

Inspire Medical Systems, Inc.

INSP

152.79 USD

Globus Medical, Inc. logo

Globus Medical, Inc.

GMED

72.46 USD

Doximity, Inc. logo

Doximity, Inc.

DOCS

59.35 USD

AptarGroup, Inc. logo

AptarGroup, Inc.

ATR

153.36 USD

Envista Holdings Corporation logo

Envista Holdings Corporation

NVST

17.77 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)